Cataract surgery with intraocular lens (IOL) implantation has been fully accepted in children over the age of 1-2 years since several years.
Disregarding single cases, reports of cataract surgery with IOL implantation in children with uveitis are lacking. In this report we describe the results of heparin coated poly(methyl methacrylate) (PMMA) IOL implantation in 10 eyes in seven children with uveitis and cataract.
Patients and methods
Seven children have undergone cataract surgery with IOL implantation in 10 eyes. They were 3.5 to 10 years old (mean age 6.5 years) at the cataract operation (Table 1) .
The uveitis was typical of that associated with juvenile rheumatoid arthritis (JRA); all eyes had band keratopathy and extensive posterior synechiae. All children had a positive test for antinuclear antibody but only three had mild joint involvement, which had been symptomatic before uveitis diagnosis in one child only. In no child were there signs of other systemic diseases.
The uveitis had been under control for several weeks at the time of surgery. Corticosteroids orally, in doses of 20-40 mg/day, and topically were used before and after surgery. Some patients were taking systemic methotrexate and corticosteroid treatment for long before surgery and received lower doses of steroids preoperatively. In one patient (patient 4), however, neither oral steroid treatment nor methotrexate was given before surgery. Topical corticosteroids were adjusted for each eye on an individual basis. Postoperatively, dexamethasone was given eight times a day and a combination of cyclopentolate and phenylephrine three times a day followed by a slow taper on an individual basis.
One surgeon (CZ) performed all surgery. A 3.2 mm scleral pocket incision was used. Posterior synechiae were lysed under viscoelastic control (Healon GV 14 mg/ml) and an anterior capsulorhexis was performed. Iris hooks were used to enlarge small pupils. After hydrodissection, mechanised irrigation/ aspiration of the nucleus and cortex was carried out. Posterior capsulorhexis was performed and the wound enlarged to the diameter of the IOL optic for implantation of a heparin surface modified (HSM) PMMA IOL (Pharmacia Upjohn type 808 C, or 809 C) in the capsular bag. Dry anterior vitrectomy was performed in five out of the 10 eyes.
Results
Four patients underwent unilateral surgery and three patients had bilateral surgery. All but one had severe uveitis with complications at the time of diagnosis. The mean follow up after cataract extraction was 28 months (Table 2) .
Visual acuity (VA) improved postoperatively in all eyes but one and best corrected VA at last check was 20/50-20/20 in all but two eyes. In patient 1, the low VA (20/80) of the left eye was a consequence of glaucoma.
In one girl (patient 4) the vision was not improved. She had five reoperations for secondary membranes and the vision was reduced Posterior capsular opacification (PCO) and secondary membranes developed in seven out of the 10 eyes and reoperation was required; two needed only Nd:YAG laser. Only one additional operation was required, except for patient 2, who had two operations, and patient 4, who had five operations.
At last check all patients were taking anti-inflammatory treatment but one showed signs of active uveitis.
Discussion
In the present series of seven children with advanced uveitis complicated by cataract, a best corrected visual acuity of 20/40 or better was attained in seven out of 10 eyes. Systemic studies of IOL implantation in children with uveitis are lacking but the visual results of IOL implantation in this small series of children are comparable with those reported in adults with uveitis. 11-14 16 Some authors have recommended pars plana vitrectomy and lensectomy with complete excision of the posterior capsule, with similar results as in the present study. 8 17 18 However, this technique commits the patient to a lifelong dependence on aphakic correction.
The operation was not performed until the uveitis had been quiescent for some weeks and recurrences did not occur perioperatively. Besides topical steroids given to all perioperatively, systemic steroids were also given to all but one (patient 4), which might have been of importance for the negative outcome in this patient.
Although the diagnostic criteria for JRA according to ILAR were not met in the present patients-only three had mild arthritis symptoms-the uveitis was of JRA type and all children had antinuclear antibodies. It is not uncommon that the uveitis antedates the arthritis and it has been reported that the visual prognosis is poor in these cases, probably due to delay in the diagnosis of the uveitis. 9 Apart from single patients with JRA associated uveitis included in the diVerent published series treated with IOL implantation there is only one study addressing IOL in this type of uveitis. This study comprised seven patients with JRA (eight eyes). 10 A visual acuity of 20/40 or better was attained in all eyes; however, only two children under the age of 10 years were included. Complications in children with uveitis treated with IOL have been reported 10 19 and in some cases removal of the IOL has been necessary. 20 However, the surgery was not standardised, diVerent IOLs were used, and the surgery was performed in several hospitals.
Membrane formation and posterior capsule opacification were common complications in our series but did not constitute a serious problem except in one patient requiring several reoperations and developing glaucoma and poor VA. Membranes also develop in uveitic eyes not undergoing surgery. 21 IOL implantation has been reported to decrease the PCO tendency in adults, 22 and in animal experiments. 23 24 A decreased tendency to recurrences and inflammation in uveitis after IOL implantation has also been reported. 25 It is possible that anterior vitrectomy diminishes PCO in children operated for cataract 26 ; of the three eyes not developing membrane formation in the present series, two had dry anterior vitrectomy at cataract surgery.
Glaucoma is a common complication of JRA associated uveitis 27 28 and in this series glaucoma had developed preoperatively in three eyes. Glaucoma evolved in three eyes 3-14 months after surgery. Two of the latter have successfully received a Molteno implant. The follow up period is short so it is possible that glaucoma may develop in more eyes in the future. 
